Recommendations for economic evaluations of non-pharmacological arthritis care: Results from the CARE VI meeting 2010

Musculoskeletal Care

Volumn 9, Issue 2, 2011, Pages 120-123

  Van den Hout, Wilbert B ^a   Bremander, Ann ^b   Vliet Vlieland, Thea P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Spenshult Hospital for Rheumatic Diseases   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DECISION MAKING; ECONOMICS; HEALTH SERVICES RESEARCH; HUMAN; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; REHABILITATION; STANDARD;

ARTHRITIS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION MAKING; HEALTH SERVICES RESEARCH; HUMANS; MULTICENTER STUDIES AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; REHABILITATION;

EID: 79957550614     PISSN: 14782189     EISSN: 15570681     Source Type: Journal    
DOI: 10.1002/msc.204     Document Type: Article

References (18)

1. Bremander A, Petersson IF, Hagen KB, Hørslev-Petersen K, Vliet Vlieland TP (2010). The feasibility of an European initiative for care research, the STAR-ETIC project (Abstract OP0245-HP, presented at EULAR 2010). Annals of the Rheumatic Diseases 69 (Suppl. 3): 727.
2. Drummond M, Weatherly H, Ferguson B (2008). Economic evaluation of health interventions. British Medical Journal 337: a1204.
3. Glasziou P, Meats E, Heneghan C, Shepperd S (2008). What is missing from descriptions of treatment in trials and reviews? British Medical Journal 336: 1472-4.
4. Harrison MJ, Davies LM, Bansback NJ, Ingram M, Anis AH, Symmons DP (2008). The validity and responsiveness of generic utility measures in rheumatoid arthritis: A review. The Journal of Rheumatology 35: 592-602.
5. Hill J, Hurley M, Li L, Vliet Vlieland T (2006). Putting caring into research - The CARE conferences. Musculoskeletal Care 4: 125-9.
6. O'Donnell S, Li LC, King J, Lauzon C, Finn H, Vliet Vlieland TP (2010). Development of a framework for reporting health service models for managing rheumatoid arthritis. Clinical Rheumatology 29: 151-65.
7. Prasad M, Wahlqvist P, Shikiar R, Shih YC (2004). A review of self-report instruments measuring health-related work productivity: A patient-reported outcomes perspective. Pharmacoeconomics 22: 225-44.
8. Roine E, Roine RP, Räsänen P, Vuori I, Sintonen H, Saarto T (2009). Cost-effectiveness of interventions based on physical exercise in the treatment of various diseases: A systematic literature review. International Journal of Technology Assessment in Health Care 25: 427-54.
9. Schwartz CE, Sprangers MA (2010). Guidelines for improving the stringency of response shift research using the thentest. Quality of Life Research 19: 455-64.
10. Stiggelbout AM, de Haes JC (2001). Patient preference for cancer therapy: An overview of measurement approaches. Journal of Clinical Oncology 19: 220-30.
11. Stiggelbout AM, de Vogel-Voogt E (2008). Health state utilities: A framework for studying the gap between the imagined and the real. Value in Health 11: 76-87.
12. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K (2009). A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers. Journal of Clinical Epidemiology 62: 464-75.
13. Ubel PA, Hirth RA, Chernew ME, Fendrick AM (2003). What is the price of life and why doesn't it increase at the rate of inflation? Archives of Internal Medicine 163: 1637-41.
14. Van den Hout WB, Tijhuis GJ, Hazes JM, Breedveld FC, Vliet Vlieland TP (2003). Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: A randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care. Annals of the Rheumatic Diseases 62: 289-90.
15. Van den Hout WB, de Buck PD, Vliet Vlieland TP (2007). Cost-utility analysis of a multidisciplinary job retention vocational rehabilitation program in patients with chronic arthritis at risk of job loss. Arthritis and Rheumatism 57: 778-86.
16. Van den Hout WB (2009). Deficiencies in current evaluations of the cost-effectiveness of biologic agents for RA. Nature Clinical Practice Rheumatology 5: 78-9.
17. Van den Hout WB (2010). The value of productivity: Human-capital versus friction-cost method. Annals of the Rheumatic Diseases 69 (Suppl. 1): i89-91.
18. Vliet Vlieland TP, de Buck PD, van den Hout WB (2009). Vocational rehabilitation programs for individuals with chronic arthritis. Current Opinion in Rheumatology 21: 183-8.